Financials

  • Market Capitalization 592.22 M
  • Employee 40
  • Founded 2022
  • CEO N/A
  • Website www.zurabio.com
  • Headquarter Cayman Islands
  • FIGI UNKNOWN
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-5.22
Rapporto prezzo/fatturato

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2825
TECX
Tectonic Therapeutic, Inc. - Common Stock
30.76 USD+2.81%-14.17%+4.31%+79.36%601.34 M USD
2853
SPRY
ARS Pharmaceuticals, Inc. - Common Stock
5.63 USD-0.71%-4.90%+5.83%-38.87%559.89 M USD
2865
CAPR
Capricor Therapeutics, Inc. - Common Stock
9.48 USD+2.16%-1.66%+127.34%+58.00%551.16 M USD
2870
OVID
Ovid Therapeutics Inc. - Common Stock
2.80 USD+0.72%-0.71%+11.11%+117.05%546.83 M USD

Notizie